Production and characterization of monoclonal antibodies to human Pneumocystis carinii for the diagnosis of P. carinii pneumonia
- PMID: 1341432
Production and characterization of monoclonal antibodies to human Pneumocystis carinii for the diagnosis of P. carinii pneumonia
Abstract
Objectives: Monoclonal antibodies against human Pneumocystis carinii were produced by fusion of myeloma cells (X63-AG8.653) with splenocytes from Biozzi mice that had been immunized against P. carinii cysts isolated from infected human lung. The aim of this study was to evaluate the usefulness of these monoclonal antibodies for the diagnosis of P. carinii pneumonia by indirect immunofluorescence in comparison with a modified silver stain method and commercial kits.
Methods: One hundred fifty-seven specimens from 87 patients, infected or non-infected with human immunodeficiency virus, were examined for the presence of P. carinii. Specimens were either induced sputum samples or bronchoalveolar lavage fluids. Indirect immunofluorescence was performed with six stable clones obtained by limiting dilution. Four of the monoclonal antibodies were IgG1 isotypes, one was an IgG3 and one was an IgM. Their isoelectric points varied from 6.5 to 8.3. Tests were also performed with silver methenamine staining and with two commercially available monoclonal antibodies (Monofluo kit from Diagnostics Pasteur and MAb from Dako).
Results: The 6 antibodies all recognized P. carinii cysts in indirect immunofluorescence. No cross reactivity was observed with yeast or host cells. P. carinii antigens could not be identified with western immunoblotting suggesting that the monoclonal antibodies recognized native antigens. This result was confirmed by dot blot analysis. Spots were observed with native but not with denatured antigens. Inhibition studies showed that these 6 antibodies recognized the same or overlapping sites. The sensitivities of detection of P. carinii in sputum were 87% by silver stain and from 93.5 to 96.7% by immunofluorescence. The sensitivities of detection in bronchoalveolar lavage were 67.3% by silver stain and from 75.7% to 76.8% by immunofluorescence.
Conclusion: Immunofluorescence was more sensitive than silver staining and the best results were obtained with E5-8 and A8-13 monoclonal antibodies and with Monofluo kit.
Similar articles
-
Laboratory diagnosis and occurrence of Pneumocystis carinii.Scand J Infect Dis Suppl. 1994;94:1-34. Scand J Infect Dis Suppl. 1994. PMID: 8059227
-
Diagnosis of Pneumocystis carinii pneumonia: improved detection in sputum with use of monoclonal antibodies.N Engl J Med. 1988 Mar 10;318(10):589-93. doi: 10.1056/NEJM198803103181001. N Engl J Med. 1988. PMID: 2449613
-
Use of a monoclonal antibody to detect Pneumocystis carinii in induced sputum and bronchoalveolar lavage fluid by immunoperoxidase staining.Arch Pathol Lab Med. 1988 Dec;112(12):1233-6. Arch Pathol Lab Med. 1988. PMID: 3056320
-
[Laboratory diagnosis of cytomegalovirus infections and pneumocystis carinii pneumonia in immunosuppressed patients].Med Klin (Munich). 1992 Oct;87 Suppl 1:14-9. Med Klin (Munich). 1992. PMID: 1334217 Review. German. No abstract available.
-
Diagnostic strategies in Pneumocystis carinii pneumonia.Front Biosci. 1998 Jan 1;3:e1-12. doi: 10.2741/a363. Front Biosci. 1998. PMID: 9405333 Review.
Cited by
-
Monoclonal antibodies as diagnostics; an appraisal.Indian J Pharm Sci. 2010 Jan;72(1):12-7. doi: 10.4103/0250-474X.62229. Indian J Pharm Sci. 2010. PMID: 20582184 Free PMC article.
-
Diagnosing Pneumocystis jirovecii pneumonia: A review of current methods and novel approaches.Med Mycol. 2020 Nov 10;58(8):1015-1028. doi: 10.1093/mmy/myaa024. Med Mycol. 2020. PMID: 32400869 Free PMC article. Review.